Navigation Links
Verdezyne Awarded BioNexus Status By Malaysian Government
Date:9/24/2013

SAN FRANCISCO, Sept. 24, 2013 /PRNewswire/ -- Verdezyne, Inc., a privately-held industrial biotechnology company focused on producing renewable chemicals, has been awarded "BioNexus" status by Malaysian Biotechnology Corporation (BiotechCorp), it was announced today at the Biotechnology International Advisory Panel (BioIAP) meeting in San Francisco, California.  BiotechCorp is an agency under the purview of the Malaysian Ministry of Science, Technology and Innovation (MOSTI). As part of its collaboration with BiotechCorp, Verdezyne expects to open a bio-based chemical production facility in Malaysia, in which Verdezyne will make a significant investment.

BioNexus status is awarded to qualified companies undertaking value-added biotechnology and/or life sciences activities in Malaysia, and includes fiscal incentives, grants and other guarantees to assist growth. Verdezyne was awarded BioNexus status by the Prime Minister of  Malaysia, The Right Honourable Dato' Sri Mohd Najib Bin Tun Haji Abdul Razak at a special announcement ceremony during the BioIAP meeting.

"We are honored to receive BioNexus Status from Malaysian BiotechCorp," commented E. William Radany, PhD, President and CEO of Verdezyne. "This status confers a wide array of support and assistance which will accelerate our goal of beginning construction of our first plant to produce renewable chemicals from vegetable oil feedstocks."

About Verdezyne
Verdezyne is an industrial biotechnology company using proven and proprietary metabolic pathway engineering tools to develop unique yeast strains for cost-effective production of bio-based chemicals. Curre
'/>"/>

SOURCE Verdezyne, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. CSHL is part of iPlant group awarded $50 million to create US biology cyberinfrastructure
2. FPC Awarded new Smartphone DW From Existing Prominent Asian OEM Customer for Launch With Leading US Operator
3. Grand Challenge grant awarded to team led by Nationwide Childrens researcher
4. 4 projects awarded Discovery Transformation Grant funding by Minnesota Partnership
5. Professor Vanessa Hayes awarded for exceptional Africa-related work
6. MIIR scientist awarded $293,000 NIH grant
7. HudsonAlpha awarded grant to improve diagnoses of childhood genetic disorders
8. LSUHSC researcher awarded NCI grant to study link between chronic inflammation and cancer
9. Kessler Foundation awarded more than $1.2 million in grants by the NJ Commission on Sci Research
10. Patent awarded today to NJIT for novel use of water jets to create high tensile strength alloy parts
11. Vijay Tiwari awarded the Bruno Speck Award 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... (Sept. 17, 2014) A rare genetic disorder known as ... a recent joint investigation by researchers at San Diego ... In addition to suggesting better treatment options for people ... into the genetic underpinnings of autism., Jacobsen syndrome affects ... Institutes of Health. It occurs in a person when ...
(Date:9/17/2014)... Mar Medical Research Institute) and at the Universitat Politcnica ... eLife showing that RNA called non-coding (IncRNA) ... proteins, some of which could have important cell functions ... instructions found in an RNA molecule. However, only 2% ... the synthesis of proteins, meaning it is coding. Other ...
(Date:9/17/2014)... 17, 2014 Researchers at UTSouthwestern Medical Center have ... protein apolipoprotein E, called apoE3, helps repair the lining ... do not get the benefit of this repair, putting ... believe that we have identified one mechanism by which ... genetic variant, apoE4, is detrimental," said Dr. Philip ...
Breaking Biology News(10 mins):A link between Jacobsen syndrome and autism 2Parts of genome without a known function may play a key role in the birth of new proteins 2Protein variant may boost cardiovascular risk by hindering blood vessel repair 2
... and use of commercial fertilisers and animal waste is ... our aquatic environment. Yet global food and bioenergy supplies ... Agriculture and Ecology at LIFE Faculty of Life ... massive resources at the development of sustainable animal waste ...
... a popular species of game fish in Lake Erie are ... most comprehensive to date on mercury levels in Great Lakes ... a semi-monthly journal. Satyendra Bhavsar and colleagues note ... lakes in the world. The lakes are of significant economic ...
... 20, 2010) -- The Howard Hughes Medical Institute (HHMI) ... Rice University,s successful undergraduate global health program Beyond Traditional ... million HHMI grant in 2006, challenges students to come ... developing world. The program has captured the imagination of ...
Cached Biology News:Massive resources now directed at sustainable animal waste technology 2HHMI renews grant for Rice's global health program 2
(Date:9/18/2014)... Sept. 18, 2014  U.S. biotech company Kultevat ... exclusive license for technology developed by the Donald ... in plants, including for applications in production of natural ... The technology was developed under the direction of ... and former president of the Danforth Plant Science Center, ...
(Date:9/18/2014)... Sept. 18, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ... announced concurrent but separate underwritten offerings of 10,000,000 shares ... public of $2.00 per share, for expected gross proceeds ... A Convertible Preferred Stock at a price to the ... of $20 million. Each share of Series A Convertible ...
(Date:9/18/2014)... OMICS Group International invites researchers, authors and academicians ... Access Week’ by actively contributing their research outcome ... from 20-26th October, 2014. , Pharmaceutical Sciences ... with a tremendous speed to provide improved medical ... is gearing with innovation and technological revolution to ...
(Date:9/18/2014)... expensive. Now a team led by an engineer at ... designs that will let scientists slash the cost of ... , Syringe pumps are used to dispatch precise amounts ... in a reaction. They can also cost hundreds or ... team of Michigan Tech students published the library of ...
Breaking Biology Technology:Kultevat obtains license of gene switch technology 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 2Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock 3Pharma and Omics Journals to Address Global Challenges during Open Access Week 2Pharma and Omics Journals to Address Global Challenges during Open Access Week 3Doing science just got cheaper -- and faster 2
... ... ... ... March 12 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ) today announced that it will restate its 2008 financial statements contained in its Annual Report on Form 10-K for the ...
... LAKE, N.J. , March 11 Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a five-day dosing regimen ... , ... , , ... ...
... China , March 11 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., Inc. ... ("TCM") based in Chengdu, China , today,announced it will present ... held March 15-17, 2010 in Dana Point, California ... Tuesday, March 16, 2010, ...
Cached Biology Technology:Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 2Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 3Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 4Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 5Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 6Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 7Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 8Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 9Oncothyreon consults with Division of Corporation Finance about accounting for 2008 License Agreement 10FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 2FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 3FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 4FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 5FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 6FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 7FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 8Tianyin Pharmaceutical Co., Inc. to Present at the 22nd Annual ROTH Capital Partners OC Growth Stock Conference on March 16 2Tianyin Pharmaceutical Co., Inc. to Present at the 22nd Annual ROTH Capital Partners OC Growth Stock Conference on March 16 3Tianyin Pharmaceutical Co., Inc. to Present at the 22nd Annual ROTH Capital Partners OC Growth Stock Conference on March 16 4
...
TNM-FH Insect Medium 1 liter...
IHC Polymer Detection Kit (Rabbit DAB)150 slides...
Performance, mycoplasma, virus, and endotoxin tested. Collected from calves 14 days old or less...
Biology Products: